NFKB1 and neoplasm: In the inflammatory microenvironment, apigenin can significantly inhibit IL-1β-induced urokinase-type plasminogen activator receptor expression and inhibit AP-1 and NF-κB transcription factors’ activities through blocking the MAPK pathway’s phosphorylation, which can prevent tumor invasion and metastasis [113].